Published in Dig Liver Dis on December 20, 2007
Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet (1996) 6.06
Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet (1998) 2.32
Obstacles to residents' conducting research and predictors of publication. Acad Med (2001) 2.25
Sequence analysis of the cloned streptococcal cell surface antigen I/II. FEBS Lett (1989) 2.11
Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther (2007) 1.61
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3. J Viral Hepat (2008) 1.45
Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl (2001) 1.40
Primary biliary cirrhosis and inflammatory bowel disease. Am J Gastroenterol (1993) 1.39
Comparison of the clinic microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids. Am J Clin Pathol (1994) 1.38
Mullerian duct anomalies: from diagnosis to intervention. Br J Radiol (2009) 1.32
Radiological features of synovial cell sarcoma. Br J Radiol (2008) 1.30
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut (2006) 1.22
Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. J Biol Chem (1990) 1.22
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. Am J Transplant (2006) 1.20
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice. Aliment Pharmacol Ther (2006) 1.07
Staining for Bcl-2 protein helps to distinguish benign from malignant lymphoid aggregates in bone marrow biopsies. Mod Pathol (1994) 1.06
Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats. J Pharmacol Exp Ther (2012) 1.02
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat (2008) 1.02
Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochem Pharmacol (2011) 1.01
Obscure gastrointestinal bleeding from an ampullary tumour in a patient with a remote history of renal cell carcinoma: a diagnostic conundrum. Can J Gastroenterol (1998) 1.01
Massive bleeding from multiple gastric ulcerations in a patient with lymphocytic gastritis and celiac sprue. J Clin Gastroenterol (1997) 0.98
Radiological imaging features of non-uterine leiomyosarcoma. Br J Radiol (2007) 0.96
Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol (1996) 0.95
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance. J Hepatol (2000) 0.94
Diminutive but dangerous: a case of a polypoid rectal arteriovenous malformation. Endoscopy (2002) 0.94
Enhanced intestinal adenomatous polyp formation in Pms2-/-;Min mice. Cancer Res (1998) 0.91
Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past. Transpl Infect Dis (2012) 0.90
The imaging features of gastrointestinal stromal tumours. Eur J Radiol (2006) 0.90
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas. Am J Gastroenterol (1999) 0.88
Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients. Neurology (2006) 0.87
Spontaneous perforation of pyometra due to acute necrotising endometritis. J Obstet Gynaecol (2011) 0.86
Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine. Transplantation (1997) 0.85
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin. Aliment Pharmacol Ther (2013) 0.84
Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis. Ann Oncol (1999) 0.84
Synovial osteochondromatosis: the spectrum of imaging findings. Australas Radiol (2005) 0.83
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin. Aliment Pharmacol Ther (2008) 0.83
Liver biochemistry abnormalities in a quaternary care lipid clinic database. Ann Hepatol (2008) 0.82
Primary protein-losing enteropathy in anti-double-stranded DNA disease: the initial and sole clinical manifestation of occult systemic lupus erythematosus? J Clin Gastroenterol (2001) 0.82
Colonic malakoplakia in a liver transplant recipient. Can J Gastroenterol (2007) 0.81
Impaired exercise performance after successful liver transplantation. Transplantation (2001) 0.80
Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C. Can J Gastroenterol (1997) 0.80
Lactulose in vincristine-induced constipation. Med J Aust (1977) 0.79
Correlation between physiological assessment and outcome after liver transplantation. Am J Surg (2000) 0.79
Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigen. Ann Surg (1999) 0.78
Localization and structure of the muscarinic receptor ligand binding site. Trends Pharmacol Sci (1989) 0.78
Novel isoforms of CaBP 33/37 (annexin V) from mammalian brain: structural and phosphorylation differences that suggest distinct biological roles. Biochim Biophys Acta (1992) 0.77
Leiomyosarcoma of the distal femur in a patient with a history of bilateral retinoblastoma: a case report and review of the literature. Skeletal Radiol (2003) 0.77
Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. Immunol Lett (1998) 0.76
Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada. Can J Gastroenterol (2008) 0.76
Hyperammonemia after heart-lung transplantation. Gastroenterology (1997) 0.76
A study of the pharmacokinetic profile of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection. Am J Transplant (2001) 0.75
Lung dysfunction and chronic liver disease. Ann Intern Med (1996) 0.75
Epigastric pain and a left upper quadrant mass in an elderly woman. Postgrad Med J (1997) 0.75
The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura. Am J Gastroenterol (1995) 0.75
Hepatitis C and B-cell non-Hodgkin's lymphoma: a geographically variable association? Am J Med (2000) 0.75
Tomorrow's challenge in liver transplantation: diminishing the imbalance between donor organ availability and need. Gut (1998) 0.75
Lovastatin and cholestasis. CMAJ (1993) 0.75
Orthotopic liver transplantation in a patient with carbamyl phosphate synthetase deficiency and cystic fibrosis. Paediatr Child Health (2003) 0.75
All that bleeds is not infliximab-refractory ulcerative colitis. Can J Gastroenterol (2009) 0.75
Crohn's disease, HIV, and AIDS. Am J Gastroenterol (1995) 0.75
Barriers to transplantation in adults with inborn errors of metabolism. JIMD Rep (2012) 0.75
Peritoneal dialysis after orthotopic liver transplant surgery. Perit Dial Int (2006) 0.75
Acute pseudohepatitis in a chronic substance abuser secondary to occult seat belt injury. Can J Gastroenterol (1999) 0.75
De Novo Crohn's disease in AIDS: Crohn's disease or Crohn's "syndrome"? J Clin Gastroenterol (1998) 0.75
Odontoid fracture following an epileptic seizure. Australas Radiol (2001) 0.75
A new perspective on the psychological effects of environmental barriers. Rehabil Lit (1977) 0.75
Rhabdoid cells in peritoneal fluid. A case report. Acta Cytol (1997) 0.75
Hepatic abscesses after liver transplantation secondary to traumatic intrahepatic bile duct injuries in a cadaveric allograft donor. Transpl Int (2004) 0.75
Diabetes mellitus after liver transplantation: another extrahepatic manifestation of hepatitis C. Can J Gastroenterol (2001) 0.75
Liver enzymes as surrogate markers of hepatitis C histopathology--avoiding the liver biopsy needle? Can J Gastroenterol (2001) 0.75
Duchenne-Landouzy dystrophy: CT explanation of low serum creatinine level. AJR Am J Roentgenol (2000) 0.75
Issues in organ procurement: presumed consent, bioethical type II errors, and organ registries. Ann R Coll Physicians Surg Can (1998) 0.75
Post-surgical shunt hepatopulmonary syndrome in a case of non-cirrhotic portal hypertension: lack of efficacy of shunt reversal. Eur J Gastroenterol Hepatol (1999) 0.75
Carcinoid tumors of the small intestine are uncommon, indolent, slow growing, slow metastasizing, neuroendocrine lesions. World J Surg (1994) 0.75
A simple method to minimize spillage on retrograde examination of the bowel in patients with an ileostomy or colostomy: technical note. Can Assoc Radiol J (2001) 0.75
Internal oblique hematoma: an alternative computed tomography diagnosis for flank pain. J Emerg Med (2001) 0.75
Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay. Liver Transpl (2000) 0.75
Palliative high-dose octreotide in a case of severe AIDS-related diarrhea. Ann Pharmacother (1994) 0.75
Recurrent hepatocellular carcinoma after liver transplantation mimicking post-transplantation lymphoproliferative disorder. Australas Radiol (2005) 0.75
Clara Chase Leach, M.D.: beloved physician. Am Baptist Q (1999) 0.75
The white chest. Chest (2001) 0.75
Primary induction with mycophenolate mofetil and corticosteroids in a liver transplant recipient with hepatorenal syndrome. Ann Pharmacother (1998) 0.75